| NCT ID | NCT05293184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation for Angelman Syndrome Therapeutics, Australia |
| Condition | Angelman Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2016-09-28 |
| Primary Completion | 2099-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2016-09-28 with a primary completion date of 2099-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Global Angelman Syndrome Registry is an online patient organisation driven registry to collect information about the natural history of children and adults with Angelman Syndrome. The registry will facilitate 1) recruitment for clinical trials into therapies and interventions to benefit participants with Angelman Syndrome and their families, and 2) advancement of research and best standards of care for Angelman Syndrome. The registry is currently available in English, Spanish, Traditional Chinese, Italian, Polish, Hindi, and Brazilian Portuguese.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Angelman Syndrome Exclusion Criteria: \-
Contact & Investigator
Megan Tones, PhD
✉ curator@angelmanregistry.infoHelen (Honey) Heussler, MBBS, FRACP DM
PRINCIPAL INVESTIGATOR
The University of Queensland
Frequently Asked Questions
Who can join the NCT05293184 clinical trial?
This trial is open to participants of all sexes, studying Angelman Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05293184 currently recruiting?
Yes, NCT05293184 is actively recruiting participants. Contact the research team at curator@angelmanregistry.info for enrollment information.
Where is the NCT05293184 trial being conducted?
This trial is being conducted at Brisbane, Australia.
Who is sponsoring the NCT05293184 clinical trial?
NCT05293184 is sponsored by Foundation for Angelman Syndrome Therapeutics, Australia. The principal investigator is Helen (Honey) Heussler, MBBS, FRACP DM at The University of Queensland. The trial plans to enroll 5,000 participants.